scholarly article | Q13442814 |
P819 | ADS bibcode | 2010PLoSO...513302B |
P356 | DOI | 10.1371/JOURNAL.PONE.0013302 |
P932 | PMC publication ID | 2951917 |
P698 | PubMed publication ID | 20949049 |
P5875 | ResearchGate publication ID | 47430537 |
P50 | author | Laura Mari Beskow | Q61638904 |
Kevin P Weinfurt | Q90980196 | ||
P2093 | author name string | Li Lin | |
N Chantelle Hardy | |||
Joëlle Y Friedman | |||
P2860 | cites work | The Health Insurance Portability and Accountability Act and the informed consent process | Q81104499 |
The Path to Personalized Medicine | Q29541502 | ||
Research ethics. Certificates of confidentiality and compelled disclosure of data | Q33384379 | ||
Quality of informed consent in cancer clinical trials: a cross-sectional survey | Q34104151 | ||
Variability among institutional review boards' decisions within the context of a multicenter trial | Q34179656 | ||
Readability standards for informed-consent forms as compared with actual readability | Q35069075 | ||
Offering individual genetic research results: context matters | Q35106928 | ||
Simplifying informed consent for biorepositories: stakeholder perspectives | Q35649408 | ||
Consent documents for oncology trials: does anybody read these things? | Q35970898 | ||
Knowledge and understanding among cancer patients consenting to participate in clinical trials | Q40042701 | ||
Informed consent for biorepositories: assessing prospective participants' understanding and opinions | Q40080444 | ||
Are informed consent forms that describe clinical oncology research protocols readable by most patients and their families? | Q40635580 | ||
Informed consent for medical research: common discrepancies and readability | Q41149163 | ||
Satisfaction with the decision to participate in cancer clinical trials is high, but understanding is a problem. | Q48855104 | ||
Reporting genetic results in research studies: summary and recommendations of an NHLBI working group. | Q55041761 | ||
The evolution of consent forms for research: a quarter century of changes | Q56779930 | ||
Longer consent forms for clinical trials compromise patient understanding: so why are they lengthening? | Q56786329 | ||
Research consent forms: continued unreadability and increasing length | Q57194770 | ||
Keeping Pace with the Times — The Genetic Information Nondiscrimination Act of 2008 | Q60016790 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | informed consent | Q764527 |
biobank | Q864217 | ||
informed consent form | Q57191389 | ||
P304 | page(s) | e13302 | |
P577 | publication date | 2010-10-08 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Developing a simplified consent form for biobanking | |
P478 | volume | 5 |
Q53665710 | A rural community's involvement in the design and usability testing of a computer-based informed consent process for the Personalized Medicine Research Project. |
Q56340754 | Analysis of VUS reporting, variant reinterpretation and recontact policies in clinical genomic sequencing consent forms |
Q93196132 | Assessing the stability of biobank donor preferences regarding sample use: evidence supporting the value of dynamic consent |
Q28706268 | Banking the brain. Addressing the ethical challenges of a mental-health biobank |
Q57778638 | Big data analytics in E-commerce: a systematic review and agenda for future research |
Q38386392 | Biobanking for Personalized Medicine |
Q34644788 | Biobanking research on oncological residual material: a framework between the rights of the individual and the interest of society |
Q37716299 | Cancer patient perceptions about biobanking and preferred timing of consent |
Q47762656 | Concise Review: Musculoskeletal Stem Cells to Treat Age-Related Osteoporosis. |
Q36072265 | Demographic differences in willingness to provide broad and narrow consent for biobank research |
Q57180636 | Developing informed consent materials for non-English-speaking participants: An analysis of four professional firm translations from English to Spanish |
Q38887000 | Development of Plain Language Supplemental Materials for the Biobank Informed Consent Process |
Q37190670 | Did I Tell You That? Ethical Issues Related to Using Computational Methods to Discover Non-Disclosed Patient Characteristics |
Q35055868 | Ethical aspects of human biobanks: a systematic review |
Q37146647 | Ethics Reporting in Biospecimen and Genetic Research: Current Practice and Suggestions for Changes |
Q91860552 | Exploring Understanding of "Understanding": The Paradigm Case of Biobank Consent Comprehension |
Q42756108 | Factors Influencing Dental Patient Participation in Biobanking and Biomedical Research |
Q38730932 | How do clinical genetics consent forms address the familial approach to confidentiality and incidental findings? A mixed-methods study |
Q90199248 | Improving Translation and Cultural Appropriateness of Spanish-Language Consent Materials for Biobanks |
Q33563766 | Improving biobank consent comprehension: a national randomized survey to assess the effect of a simplified form and review/retest intervention |
Q35108262 | Informed consent for biobanking: consensus-based guidelines for adequate comprehension |
Q34628608 | Informed consent, big data, and the oxymoron of research that is not research |
Q38263412 | International requirements for consent in biobank research: qualitative review of research guidelines |
Q37354569 | Lessons from HeLa Cells: The Ethics and Policy of Biospecimens |
Q36765371 | Lessons that newborn screening in the USA can teach us about biobanking and large-scale genetic studies |
Q50573711 | Long-Term Recall of Elements of Informed Consent: A Pilot Study Comparing Traditional and Computer-Based Consenting. |
Q28654661 | Open access data sharing in genomic research |
Q36687007 | Optimizing Enrollment of Patients into Nephrology Research Studies |
Q41661818 | Permission form synopses to improve parents' understanding of research: a randomized trial |
Q33455578 | Potential bias in the bank: what distinguishes refusers, nonresponders and participants in a clinic-based biobank? |
Q28661607 | Practice variation across consent templates for biobank research. a survey of German biobanks |
Q36809686 | Public support and consent preference for biomedical research and biobanking in Jordan |
Q36947352 | Reflexive research ethics in fetal tissue xenotransplantation research |
Q38125958 | Research ethics in the post-genomic era. |
Q47547328 | Routinely collected data for randomized trials: promises, barriers, and implications |
Q28710019 | SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials |
Q92642124 | Secondary Use of Patient Tissue in Cancer Biobanks |
Q46741774 | Standard Versus Simplified Consent Materials for Biobank Participation: Differences in Patient Knowledge and Trial Accrual |
Q34627212 | Strategies for enrollment of African Americans into cancer genetic studies |
Q29248789 | The Establishment of the First Cancer Tissue Biobank at a Hispanic-Serving Institution: A National Cancer Institute–Funded Initiative between Moffitt Cancer Center in Florida and the Ponce School of Medicine and Health Sciences in Puerto Rico |
Q26853408 | The evolution of biobanking best practices |
Q36931470 | Tissue banking, bioinformatics, and electronic medical records: the front-end requirements for personalized medicine |
Q47548229 | Translating Biobank Science into Patient-Centered Language |
Search more.